Connect with us

Life Sciences

Researchers develop new tools for precise large DNA insertions

GAO Caixia’s group from the Institute of Genetics and Developmental Biology of the Chinese Academy of Sciences (CAS) has developed a new genome editing…

Published

on

This article was originally published by BioEngineering

GAO Caixia’s group from the Institute of Genetics and Developmental Biology of the Chinese Academy of Sciences (CAS) has developed a new genome editing technology that achieves efficient and precise targeted insertion of large DNA segments in plants.

The development and optimization of PrimeRoot editors

Credit: IGDB

GAO Caixia’s group from the Institute of Genetics and Developmental Biology of the Chinese Academy of Sciences (CAS) has developed a new genome editing technology that achieves efficient and precise targeted insertion of large DNA segments in plants.

The new technology, called prime editing-mediated recombination of opportune targets (PrimeRoot), combines an optimized dual-ePPE editor protein previously published by the group with a highly efficient tyrosine site-specific recombinase, Cre. It can achieve one-step, precise targeted insertion of large DNA segments in rice and maize with an efficiency up to 6% and has been used to successfully insert DNA segments up to 11.1 kb.

The results were published in Nature Biotechnology on April 24.

Genome editing is a disruptive biotechnology with broad impact across the life sciences. In the decade since the first grounding-breaking CRISPR-Cas9 studies, the field has evolved from random, sporadic editing to precise editing technologies. While base editing and prime editing are efficient at making small DNA changes, they are unable to edit large cargoes. As the field of genome editing advances, there is a growing need for efficient, targeted, large DNA insertions into the genome of living cells.

Compared with the traditional, non-precise non-homologous end joining strategy, PrimeRoot has significantly improved the efficiency of inserting long DNA segments of 5 kb and above. Importantly, the insertion events are completely precise and predictable.

In this study, the researchers demonstrated two specific applications of PrimeRoot editing. PrimeRoot was used to insert an actin promoter (1.4 kb) upstream of the endogenous OsHPPD gene. The introduction of foreign functional elements is an important genetic breeding approach to regulate endogenous gene expression.

PrimeRoot was then used to perform targeted gene insertion in plants. Traditional methods based on Agrobacterium mediation and particle bombardment result in random and imprecise insertion events.

The researchers used PrimeRoot to accurately insert the rice blast resistance gene pigmR into a predicted genomic safe harbor to achieve rapid disease resistance breeding.

To enhance the efficiency of PrimeRoot, the researchers established a sequential transformation system in rice.  This system further improved editing efficiency two to four times in comparison with a single one-shot transformation, thus achieving efficiencies up to 8.3% for inserting an actin promoter (1.4 kb) and efficiencies up to 6.3% for inserting an entire pigmR gene expression frame (4.9 kb).

This technology provides strong technical support for plant molecular breeding and plant synthetic biology research.

This study was supported by the National Key Research and Development Program of China and the Strategic Priority Research Program of CAS, among others.



life sciences

Life Sciences

Wittiest stocks:: Avalo Therapeutics Inc (NASDAQ:AVTX 0.00%), Nokia Corp ADR (NYSE:NOK 0.90%)

There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well…

Continue Reading
Life Sciences

Spellbinding stocks: LumiraDx Limited (NASDAQ:LMDX 4.62%), Transocean Ltd (NYSE:RIG -2.67%)

There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well…

Continue Reading
Life Sciences

Asian Fund for Cancer Research announces Degron Therapeutics as the 2023 BRACE Award Venture Competition Winner

The Asian Fund for Cancer Research (AFCR) is pleased to announce that Degron Therapeutics was selected as the winner of the 2023 BRACE Award Venture Competition….

Continue Reading

Trending